Buy your tickets to the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach: www.eventbrite.com/e/238697028237/?discount=PSYCHSPOTLIGHT15
Introducing the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach, where leaders of the biggest publicly-traded psychedelics companies will mix and mingle with investors from across North America.
The most influential names in the psychedelics world will be attending, including Kevin O’Leary of Shark Tank fame, Rob Barrow, CEO of MindMed, and Doug Drysdale, CEO of Cybin. The CEOs of the following companies will also be attending: Irwin Naturals; Filament Health; Wesana; Enveric Biosciences; Psyched Wellness; and many, many more!
The Psychedelics Capital Conference will be full of unique networking opportunities for psychedelic stock investors and insights into this burgeoning space. In short, it is a chance to be in the room with the leaders of the psychedelics industry.
In other words, this is your chance to get the information and contacts that you need to successfully navigate the world of psychedelic stocks.
Now, you are probably thinking that an event like this must be VERY expensive, but that is shockingly not the case. In fact, you can attend for as little as $247. Plus, for a limited time only, Psychedelic Spotlight has obtained a 15% off promo code: PSYCHSPOTLIGHT15. This code works on all tickets, though hurry, as they are almost sold out.
Get your tickets now!
Follow us on Twitter: @PsycSpotlight
Follow us on Instagram: @psycspotlight
Like us on Facebook: https://www.facebook.com/PsychedelicS…
To learn more about the emerging psychedelics industry, visit:
#Psychedelics #Investing #Stocks
Have you heard about our new community?
We’re excited to announce Bonfire -
a personal growth community for people who are interested in psychedelics.
Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.